Introduction
The Philadelphia chromosome is a cytogenetic abnormality that results from reciprocal chromosomal translocations t(9; 22) (q34, qll) and it is characteristic of cells from patients with chronic myelogenous leukemia (CML) [l] . The translocations can be subdivided into two types: KZX and L6 translocations.
Both translocations result in the formation of the BCR-ABL fusion gene, which encodes two types of mRNA: b3a2 mRNA (consisting of BCR exon 3 and ABL exon 2) and b2aZ mRXA (consisting of BCR exon 2 and ABL exon 2; Figure la) [Z-7] . Both these mRNAs are translated into a protein of 210 kDa (pZ10"'.'KY4HL), which is unique to malignant CbIL cells [8] .
In designing ribozymes and antisense DNA that can disrupt expression of a chimeric RXA specifically, it is necessary to target the junction sequence. Otherwise, expression of normal mRNAs that share part of the sequence of the chimeric RIiA will also be affected, with resulting damage to host cells. In the case of b3aZ mRNA, a site potentially susceptible to cleavage by the hammerhead ribozyme is located three nucleotides upstream from the junction (Figure lb) . A conventional hammerhead ribozyme might therefore be expected to cleave specifically the abnormal b3a2 mRNA generated from K28 translocations. Indeed, several examples of such cleavage have been reported [9-161. In contrast, in the case of b2a2 mRNA. which results from I,6 translocations, as well as in the case of some K28 translocations (Figure la) , there are no hammerhead ribozyme target sequences within two or three nucleotides of the BCR-ABL junction. When the cleavage site is located further from the junction, nonspecific cleavage of normal mRNAs by hammerhead ribozymes cannot be avoided (Figure 1 b) . Previous attempts at engineering specific cleavage by the hammerhead ribozyme have involved a combination of a long antisense arm, which recognizes the junction, and a ribozyme sequence [17, 18] . Hammerhead ribozymes can cleave RNAs even if one of the binding arms is only two or three nucleotides long [19,.20] . We note that ribozymes other than the hammerhead, such as the hairpin, might cleave the BCR-ABL junction of b2aZ mRNA specifically and might, therefore, be worth investigating further. In the case of antisense DNAs, oligonucleotides of a certain length are necessary for stable binding of the antisense molecule to its target, resulting in decreases in specificity [Zl-271. The utility of such antisense-type ribozymes (and antisense D&As) remains questionable because of their low specificity [21-291. In a recent study, Santoro and Joyce [30] successfully selected DNA enzymes that were able to cleave RNA molecules with any sequence by use of a selection procedure in a&.
These DNA enzymes are rather similar to conventional hammerhead ribozymes because they consist We are interested in the specific cleavage of b2a2 mRNA. There are several sites of potential cleavage by the DIVA enzymes within three nucleotides of the BCR-ABL junction in this mRNA. We demonstrated previously that the DNA enzymes specifically cleave BCR-ABL chimeric LO (bZa2) mRh'A in aitro [28] . We found that our DNA enzyme, designated Dz3 (which originated from a type II DNA4 enzyme). was the most efficient of all those that we tested [28] . The usefulness of Dz3 in GV remained to be examined, however. In this study. we investigated the activity and specificity of Dz3 in cultured cells. To cleave a chimeric mRNA such as BCR-ABL mRNA. specific recognition of abnormal mRI%A and the absence of any effect on normal mRNA are essential. Accordingly, we also investigated the effects of introducing modified oligonucleotides into Dz3 on specificity and cleavage activity in mammalian cells using reporter constructs that included a luciferase gene. In addition, we monitored cleavage of an endogenow target in leukemic BVI 73 cells.
Results and discussion
Design of DNA enzymes and stability of DNA enzymes in human serum The design of the DNA enzymes and the choice of the target site for the specific cleavage of L6 BCR-iLBL (b2aZ) arms. In general, for efficient catalysis Z+Z v&o, the length of the antisense arms that recognize the target sequence and the introduction of modified oligonucleotides to enhance resistance to nucleases in viva are both important. We therefore prepared longer-armed Dz3 (LDz3) and several modified Dz3 forms, as shown in Figure 2a . LDz3 has binding arms of 15 nt each. SDz3 and SLDz3 corresponded to Dz3 and LDz3 but have two phosphorothioate substitutions at both their 5' and 3' ends (for a total of four modifications). MeODz3 corresponds to Dz3 but has two 2'-O-methyl-substituted residues at both the 5' and the 3' ends (for a total of four modifications).
To confirm the nuclease resistance of the modified DNA enzymes, we analyzed the stability of Dz3, SD23 and MeODz3 in human serum. Fully 3ZP-labeled oligonucleotides were incubated in 90% human serum (collected as described in [45] ) for 5, 20 and 60 min at 37°C and the products were analyzed by electrophoresis on a 20% polyacrylamide/7 M urea denaturing gel. As can be seen in Figure 2b , significant portions of the Dz3 were degraded after 60 min. In contrast, the modified SDz3 and MeODz3 remained intact, even after a 60 min incubation. It is clear, therefore, that introducing two phosphorothioate linkages or two 2'-O-methyl-substituted residues at both the 5' and 3' ends (for a total of four modifications) significantly enhanced resistance to nucleases.
Cleavage activities and specificities of DNA enzymes for the chimeric BCR-ABL L6 (b2a2) mRNA substrate Before examining the DNA enzymes in mammalian cells we investigated the effects of the modifications described above on cleavage activity and specificity against the chimeric BCR-ABL (b2a2) substrate and the normal ABL substrate (which are 121 and 92 nt long, respectively). The relative cleavage activities and the specificities of each DNA enzyme for the chimeric BCR-ABL substrate (121-mer) and the normal ABL substrate (92-mer) are shown in Figure 3 . Reactions were performed in 50 mM Tris-HCl (pH 8.0) and 25 mM MgCl, under enzyme-saturating (single-turnover) conditions at 37°C. Each of the DNA enzymes cleaved the BCR-ABL substrate at the Table 1 Kinetic parameters of cleavage of the BCR-ABL substrate mRNA (Ill-mer). anticipated site, and neither the thio substitutions nor the 2'-Me0 residues significantly inhibited the cleavage activity (Dz3, lanes 2-4; SDz3, lanes 8-10; hleODz3, lanes 14-16; Figure  3a ). These results were not surprising because the introduced modifications were sufficiently far from the catalytic domain, as had also been the case for modified synthetic hammerhead ribozymes [45--49] .
Highly specific DNA enzymes should cleave only the chimeric BCR-ABL substrate. In contrast, DNA enzymes with reduced specificity would be expected to cleave not only the chimeric BCR-ABL substrate but also the normal ABL mRXA because one of the two recognition arms of our various DNA enzymes can hybridize with part of the normal ABL mRNA. As can be seen from Figure 3b , the modifications by themselves did not affect the specificity of the DNA enzymes and no products of cleavage of the normal mRXA were detected (Dz3, lanes 2-4; SDz3, lanes 8-10; MeODz3, lanes 14-16). In contrast, however, DNA enzymes that have longer binding arms (LDz3 and SLDz3) did cleave the normal ,4BL mRNA to a limited extent; this result indicates that these DNA enzymes with their relatively long antisense arms recognized not only the abnormal BCR-ABL mRNA but also the normal ABL mRNA as substrate. Nonspecific cleavage of normal ABL mRI%A occurred when we used longer-armed DNA enzymes in &PO. This is because, in order to amplify the detection of the nonspecific cleavage, we used high concentrations of Mga+ (25 mlC1 MgClJ in the in vitro experiment. We should mention that the same longer-armed DNA enzymes acted with high specificity within mammalian cells, as discussed belovv.
In order to characterize in further detail the properties of the modified DNA enzymes and the longer-armed D&A enzymes, we determined kinetic parameters for the cleavage of the BCR-ABL 121-mer mRNA substrate under single-turnover conditions. The kinetic parameters (k,,, and K,,) are summarized in Table  1 . Comparisons of kinetic parameters revealed the absence of any significant differences in k,,, and K,, values between the modified and the unmodified DNA enzymes (Table 1 ). In the case of the longer-armed DNA enzymes, which have approximately twice as many nucleotides in their binding arms as the parental DNA enzymes, we found that the longer the binding arms, the higher the k,,, values and the lower the K, values (i.e. overall higher ficar/K4r values; Table 1 ). In terms of k,,,lK,, Dz3 was shown previously to be more powerful when a short synthetic oligonucleotide substrate of 21 nt was used [%I. It is generally accepted that long mRNAs, because of their higher-ordered structures, are cleaved less efficiently by ribozymes than corresponding short synthetic oligoribonucleotide substrates [SO-521. This was also the case for cleavage by DNA enzymes (data not shown).
Comparison
of the intracellular activities and specificities of the unmodified and modified DNA enzymes using a reporter construct in cultured cells Having confirmed the specificities and activities of our series of DNA enzyme in h-o, we next examined their effects in cultured cells using a reporter construct. In order to distinguish between the chemical-cleavage activities of our DN.4 enzymes and their antisense effects, we prepared both inactive DNA enzymes and antisense oligonucleotides as controls. As shown in Figure 4a , antisense DNA (D-antisense), which consisted entirely of deoxyribonucleotides, had a sequence complementary to the target sequence of Dz3. The modified antisense molecule, S-antisense, had two phosphorothioate substitutions at its 5' and 3' ends, as did SDz3. To identify an inactive DXA enzyme, we synthesized three variants of Dz3 (G,,-+A, GZZ-+A and A2,-+G in Figure 4b ) and examined their cleavage accivities in 2:&o. G,,A has an A residue instead of G,4 in the parental Dz3. G,,A and A,,G have A and G residues instead of the GLZ and A,, residues in the parental Dz3, respectively. Cleavage of the BCR-ABL substrate (121-mer) by these DI%A enzyme variants is shown in Figure 4b . Because G,,.4 had no cleavage activity, even when incubated with the substrate for 6 h, we used it as an inactive DIVA enzyme in subsequent studies, renaming it IDz3 ( Figure Ib) . \Ve also prepared thio-substituted IDz3, which we named SIDz3. 
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Thioasubstituted residues Figure 6 , the inactive DNA enzyme IDz3 did not have any inhibitory effect on the expression of the BC'R-LlBL-luciferase gene or the ABl..-luciferase gene. This result also demonstrates that the inhibitory effects of the DNA enzymes did not originate from antisensc effects but from the specific chemicalcleavage activity of the DKA enzymes themselves. hforeover, although the inactive DNA enzymes could potentially promote RNase-H-mediated cleavage of the substrate as observed in experiments NI cifm ( Figure 7 ; the level of RNase H was adjusted such that both DNA-enzymeand RNase-H-mediated cleavage products were discernible on the gel), the results shoun in Figure 6 clearly demonstrate that the inhibitory effects of DNA enzymes did not originate from the RIKase H activity in cells. Apparently. the specific chemical-cleavage activity of the DNA enzymes was significantly higher than the RNase-H-mediated cleavage activity in eizw, at least under the conditions of our investigations. The inhibitory effects of the thio-substituted oligonucleotides were also tested at higher concentrations (10 @/I, data not shown). In this assay, in contrast to the experiments summarized in Figure 6 (in which the oligonucleotides and the target-gene-expressing plasmid were simultaneously added to cells), because of the higher concentrations of oligonucleotides used, the target-geneexpressing plasmids were introduced first to cells with Lipofcctin and then, 2 h after incubation, the oligonucleotides were introduced to the cells again using Lipofectin.
As a result, when the oligonucleotides were introduced, the cells had already produced some luciferase, reflecting the higher background level of luciferase activity. Here again, in agreement with the results shown in Figure 6 , the DKA enzymes. with the exception of the thio-substituted enzymes, suppressed the expression of the BCR-AM-luciferase gene in mammalian cells both specifically and with high efficacy (data not shown).
In contrast to the thio-substituted DNA enzymes, the DNA enzyme with two 2'-methoxy-substituted residues at each end (MeODz3) specifically and effectivrely suppressed expression of the BCR-ABL-luciferase gene in cultured cells. This result suggests that such a Di%A enzyme could potentially be used in CZ'UO and also suggests that 2' methoxy groups are suitable for modifying such enzymes. Introducing phosphorothioate linkages, which resulted in nonspecific damage not only to the abnormal gene but also to the normal gene, seems to be less suitable. In designing oligonucleotides with the potential to disrupt chimeric RNAs, it is necessary to avoid nonspecific effects by the introduced modifications on normal genes.
Efficacies and specificities of the unmodified and modified DNA enzymes against an endogenous BCR-ABL cellular target in BV173 cells Because our DNA enzymes acted with high efficacy and specificity against a reporter-gene construct in HeLa cells, we decided to examine the activity of the DNA enzymes against an endogenous BCR-ABL (L6 bZa2 mRNA) cellular target. Because BV173 cells, which were originally derived from a CML patient, are Philadelphia chromosome-positive, they express the endogenous gene target Figure 5b ).
We first examined MeODz3 as the best representative example of our DNA enzymes. We expected that it would exhibit high efficacy and specificity: in addition to nuclease resistance, we examined its effects on H9 and BV173 cell morphology.
Upon introduction of MeODz3, an examination of BV173 cells by light microscopy, after staining with the DK.A-binding fluorochrome Hoechst 33342, revealed typical apoptotic morphology, which included condensed chromatin, fragmented nuclei and shrunken cell profiles (Figure 8a , bottom right). It was clear that MeODz3 caused apoptotic cell death specifically in BV173 cells and had no similar effect on normal H9 cells ( Figure Xa, top right) . As In order to analyze quantitatively the efficacies and specificities of three of our DNA enzymes, Dz3, SDz3 and hIeODz3, in BV173 and H9 cells, we examined the ability of cells to exclude trypan blue dye after transfeccion with each DNA enzyme in combination with Lipofectin. As can be seen in Figure Xb Figure 6 ). In most studies, antisense oligonucleotides are added several times periodically to cells; we added each DNA enzyme to cells only once in the present study. The decrease in the relative number of apoptotic cells 8 h after addition of Dz3 and 36 h after the addition of SDz3 is most probably due to degradation of the DNA enzymes by nucleases. hleODz3 had the longestlasting continuous activity against the endogenous target gene, a result that underlines, yet again, the appropriate nature of the 2' methoxy modification.
Evidence against the cleavage of RNAs during their isolation procedures in vitro Because the DNA4 enzymes were expected to overcome the BCR-/lBL-mediated inhibition of apoptosis by cleaving BCR-ABL mRKA.
we tried to detect the anticipated cleavage products directly using h'orthern blotting analysis ( Figure  9 ). It is possible that the target mRNAs were cleaved by the DX4 enzymes during the RiXA extraction & Biology 1999, Vol 6 No 4 Figure 9 process. In order to exclude this possibility, a parallel, control experiment was set up. Total RNA from BV173 cells that did not contain DNA enzyme was extracted with the extraction buffer (a monophasic solution of phenol; see the Materials and methods section) that contained the active DNA enzyme MeODz3.
I_Jsing Northern blotting analysis, we were only able to detect intact BCR-ABL mRlNA: no cleavage products were detected (data not shown). This finding is in agreement with our previous result with ribozymes [29] . In a control experiment, cells (BaF3/p210BCR7H-qRk cells) expressing only the target RX4 (substrate) were mixed, just before the RNA-isolation procedure, with cells (transformed BaF3 cells) that expressed only the ribozyme, and the total RNA was isolated from the mixture [29] . Northern blotting didn't detect any cleavage products, a clear demonstration that the cleavage had occurred within the cells but not during the R&A isolation procedure in GPO. These results led us to the conclusion that the apoptosis observed was a result of cleavage of BCR-ABL mRNA by the ribozyme, with resultant depletion of p210RCR-ABL protein in the hematopoietic cells (the p210BCR-1H', protein is a cytoplasmic, membrane-associated protein that has a constitutively high level of tyrosine kinase activity that prolongs the survival of hematopoietic cells by inhibiting apoptosis). Figure 9 ) and the cleavage product (about 5.3 kilobases; bottom band) were exactly as anticipated. The two middle bands are nonspecific and thus could be washed off by more extensive and rigorous washing at a higher temperature when a longer probe was used (data not shown; a shorter probe was used in Figure 9 ). Because the bands were sharper in the Northern blotting data shown in Figure 9 than those obtained with the longer probe, we display those ICorthern blotting data with nonspecific bands in Figure 9 . No reduction in the level of expressed L6 BCR-ABL mRNA and no cleaved product was detected in the presence of the inactive DNA enzyme IDz3 (Figure 9a ). In contrast, in all cases of treatment with active DNA enzymes, we detected cleaved fragments (Figure 9b-d) . Although the Dz3-cleavage product was detected in total RNA extracted 4 and 8 h after the addition of Dz3, the cleaved product disappeared and the amount of intact L6 BCR-ABL mRN,4 returned to the basal level after prolonged incubation (consistent with the results in Figure 8b ). In the case of SDz3, the cleaved product was also detected, indicating that SDz3 retained cleavage activity in cells in spite of the nonsequence-specific effects due to phosphorothioate linkages. Most importantly, it was clear that the amount of cleaved product was larger and the product was continuously detectable for a longer time in cells treated with MeODz3
( Figure 9d ) than in cells treated with Dz3 or SDz3.
Detection
of the cleaved fragment proved that the DNA enzymes were catalytically active in cultured cells. hloreover, we confirmed that the apoptosis of cells, as shown in Figure 8, Among the limited modifications that we introduced, 2'-OMe-substitution appeared to be the most effective, because introduction of two such modifications at each end of our DNA enzyme (MeODz3) resulted in significant resistance to nucleases without any loss of specificity.
In contrast, using a thio-substitoted version of the same DNA enzyme (SDz3) resulted in complete loss of specificity despite an increase in nuclease resistance.
In developing nucleic-acid drugs for treating CML, in particular in the case of the L6 translocations on which we focused our attention in this study, conventional ribozymes (with exception of a new motif described in [29,56,67]) might not be the best choice because of the lack of a suitable cleavage site in the target mRNA [28] . Similarly, because of a lack of substrate specificity against the chime& target, antisense oligonucleotides might also not be appropriate.
In contrast, the DNA enzymes used here exhibit high specificity for the chimeric target. Because DNA enzymes are easier to synthesize, easier to handle and more stable in z&o than ribozymes, appropriately modified DNA enzymes might turn out to be powerful catalytic nucleic-acid drugs. 
Materials and methods

Synthesis
